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Previewstheoretical paradigm that CD301b+ DCs
under the transcriptional control of IRF4
are required for the development of Th2
cell-mediated responses in vivo. Further
studies will be required to demonstrate
the practical result of the loss of DC-
Irf4 on Th2 cell-driven atopic dermatitis,
allergy, or the clearance of pathogens.
A deeper understanding of the function
and key partners of IRF4 in DCs will be
required in order to fully elucidate their
role in skewing Th2 versus Th17 cell-
mediated immunity. In the meantime
Gao et al. (2013) and Kumamoto et al.
(2013) have extended our understanding
of the DC subsets which ‘‘help 2’’ polarize
T cells.REFERENCES
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Despite the discovery of the cytokine over 20 years ago, the relevant biological sources of interleukin-9 (IL-9)
have remained amystery. In this issue of Immunity, Licona-Limo´n et al. (2013) use a newly generated reporter
mouse to demonstrate a role for IL-9-secreting T cells in helminthic parasite immunity.Interleukin-9 (IL-9) was initially identified
on the basis of its ability to promote
T cell and mast cell growth (reviewed in
Goswami and Kaplan, 2011). Consistent
with the association between IL-9 and
type 2 immune responses, IL-9 promotes
allergic inflammation and immunity to hel-
minthic parasites. However, the relevant
sources of IL-9 during immune responses
are still incompletely defined, at least
partly because of a lack of genetic tools
for tracking IL-9-expressing cells. Re-
ports have documented IL-9 production
frommast cells and several T cell subsets,
including T helper 2 (Th2), Th17, and reg-
ulatory T cells, as among the potential
sources. The most potent producers of
IL-9 are innate lymphoid cells (ILCs) and
Th9 cells, which are derived in vitro in
the presence of the cytokines transform-
ing growth factor b (TGF-b) and IL-4
(Kaplan, 2013; Wilhelm et al., 2011) (Fig-ure 1). IL-9-producing ILCs are observed
in protease-induced allergic airway
inflammation and most likely contribute
to the proallergic milieu. Th9 cells are
also capable of promoting allergic inflam-
mation in several models. As of yet, no
comprehensive studies have examined
the source of IL-9 during helminthic para-
site infection. In this issue of Immunity,
Licona-Limo´n et al. (2013) describe the
generation of new IL-9-deficient and IL-9
reporter mice that make an important
contribution to our understanding of the
sources of IL-9 during the development
of immunity to Nippostrongylus brasilien-
sis, as well as the IL-9 target cells that
might be important for parasite clearance.
Helminthic parasite clearance depends
upon the development of Th2-cell-regu-
lated immune responses (Urban et al.,
1998), although it is understood that
many of the cytokines and transcriptionfactors that promote Th2 cell develop-
ment are also required for Th9 cell differ-
entiation. The requirement for IL-9 in
parasite immunity is less clear. Perhaps
owing to redundancy in function among
Th2-cell-type cytokines and IL-9, IL-9-
deficient mice on a mixed genetic back-
ground were able to clear N. brasiliensis
infection, although transgenic or exoge-
nous IL-9 clearly enhanced immunity to
additional parasites (reviewed in Gos-
wami and Kaplan, 2011). The reason for
differences among these models is un-
clear but suggests that the role of IL-9 in
parasite immunity is more complex and
might vary with pathogen, genetic back-
ground of the host, or other experimental
variables.
In this issue of Immunity, Licona-Limo´n
et al. generated Il9/ mice on a BALB/c
genetic background and a novel IL-9 re-
porter mouse by placing an IRES-EGFP, October 17, 2013 ª2013 Elsevier Inc. 627
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Figure 1. IL-9-Dependent Immunity
The schematic identifies IL-9-producing T cells (Th9 cells) and ILCs as major
sources of IL-9. IL-9 promotes growth of mast cells and basophils and Th2
cytokine production so that each can contribute to the clearance of gastroin-
testinal worms.
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Previewscassette, termed INFER
(Interleukin Nine Fluorescent
Reporter), downstream of Il9
(Licona-Limo´n et al., 2013).
Consistent with previous
reports on mice with a
disrupted Il9 allele on a mixed
genetic background (Town-
send et al., 2000), these mice
showed no gross abnormal-
ities in development or repro-
duction. However, in contrast
to 129 3 C57BL/6 (F2) Il9
/
miceused in previous studies,
the BALB/c Il9/ mice
demonstrated diminished
clearance of N. brasiliensis.
The INFER allele reported
accurately for IL-9 expres-sion; GFP was observed predominantly in
Th9 cell cultures and had minimal expres-
sion in other Th cell subset cultures, and
about 80% of the IL-9-positive cells were
also positive for GFP. This result repre-
sents far greater fidelity of gene expression
reporting than did a previously described
Il9 reporter that only identified about 10%
of IL-9-secreting T cells in culture (Wilhelm
et al., 2011). Although there are caveats in
the use of any reporter allele,mice carrying
the INFER allele represent an important
reagent going forward in understanding
IL-9 biology. Licona-Limo´n et al. (2013)
used these new mouse models to add
to several important paradigms regard-
ing the mechanisms of IL-9-dependent
immune responses.
During N. brasiliensis infection, Il9 re-
porter activity is observed in both CD4+
T cell and ILC populations. Although the
experiments presented in this report do
not distinguish between these sources of
IL-9 in terms of their relative contribution
to immunity, their results suggest that
GFP+ ILCs outnumber GFP+CD4+ T cells
in the lungs but that GFP+CD4+ T cells
predominate soon after infection in the
mediastinal lymph nodes. The differences
in abundance in separate locations might
indicate distinct roles for each IL-9-
secreting population. However, the
authors demonstrate that transfer of
GFP+ Th9 cells to an Il9/ recipient re-
sults in decreased worm burden. Thus,
Th9 cells, as the only source of IL-9 in vivo,
are sufficient to mediate parasite immu-
nity, and IL-9 from ILCs is clearly not
required to mediate IL-9-dependent
clearance of N. brasiliensis.628 Immunity 39, October 17, 2013 ª2013 ElThe authors add support to the para-
digm that IL-9 appears as an early cyto-
kine during type 2 immune responses by
specifically demonstrating this during
N. brasiliensis infection. Licona-Limo´n
et al. observed that Il9 mRNA peaked
3–5 days earlier in infected target organs
and peripheral lymphoid tissue than did
mRNA encoding the Th2-cell-type cyto-
kines IL-4, IL-5, and IL-13. This is consis-
tent with observations in a house dust
mite model of airway inflammation where
IL-9 preceded Th2 cell cytokines, as well
as in atopic infants, in whom IL-9 is signif-
icantly increased in serum early in life,
before Th2 cell cytokines, but does not
stay elevated as the atopic infants age
(Jones et al., 2012; Yao et al., 2013). The
early production of IL-9 suggests a role
for IL-9 in the induction of Th2 cell
cytokines, consistent with a requirement
for Th2 cell cytokines in IL-9-induced
allergic inflammation (Temann et al.,
2002; Yao et al., 2013). The mechanisms
behind this sequential induction are not
clear. Given that IL-4 is required for thedif-
ferentiation of both Th9 and Th2 cells,
these results suggest either that TGF-b
predominates during the induction of
type 2 responses and represses IL-4-
inducedTh2 cell development or that early
Th9 cell development might arise through
IL-4-independent mechanisms. Further
experiments will be able to distinguish
these possibilities.
Among the still unanswered questions
in IL-9 biology is which IL-9-responsive
cells mediate cytokine effects during
immune responses. The authors demon-
strate that transferred GFP+ Th9 cellssevier Inc.promote increased mast cell
numbers, consistent with pre-
vious reports (Jones et al.,
2012), but also increased
basophil cell numbers in in-
fected tissues and peripheral
lymphoid organs. Moreover,
the authors demonstrate that
basophil accumulation in Th9
cell recipients is IL-9 depen-
dent. Among myeloid cells,
Il9ra was expressed in mast
cells and basophils in far
higher amounts than in eosin-
ophils and neutrophils, sug-
gesting that both populations
are important IL-9 targets.
Yet, it is still not clear which,
if either, of these cell types isthe critical responder in IL-9-mediated
parasite clearance (Figure 1).
Licona-Limo´n et al. also demonstrate a
functional difference between Th9 and
Th2 cells, an important observation given
the extensive functional overlap between
the two subsets. Transfer of Th2 or Th9
cells into infected Rag2/ recipients re-
sulted in a decrease in parasite burden
only in Th9 cell recipients. Decreased
parasite burden in Th9 cell recipients
correlated with the ability of Th9 cells,
but not Th2 cells, to increase mast cell
and basophil numbers in the lungs and
spleen. In contrast, Th2 cells, but not
Th9 cells, induced a modest increase in
eosinophil numbers in draining lymph
nodes. This suggests that Th2 and Th9
cells do have distinct or at least special-
ized functions as they cooperate in the
regulation of immunity.
The report by Licona-Limo´n et al.
strongly supports a functional role for
IL-9-secreting T cells during immune re-
sponses, a role that had been questioned
from work using the previous Il9 reporter
allele (Wilhelm et al., 2011). How Th9 cells
contribute to immunity and inflammation
is still not clear, but the identification of ba-
sophils, mast cells, and Th2 cell cytokine
production as targets of IL-9 provides
both insight into the process and avenues
for further exploration (Figure 1). The rea-
sons for the differences observed in the
contribution of IL-9 to N. brasiliensis infec-
tion between Licona-Limo´n et al. (2013)
and Townsend et al. (2000) are not clear.
The differing genetic background of the
micemight suggest thatmicewith amixed
genetic background are less reliant upon
Immunity
PreviewsIL-9-dependent mechanisms that include
growth and recruitment of mast cells and
basophils or lung and intestinal goblet
cell metaplasia in parasite immune re-
sponses. On the basis of these studies,
the new tools generated by Licona-Limo´n
et al. will allow researchers to INFER
further insight into the role of IL-9 in immu-
nity and inflammation.
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Blood CXCR5+ CD4+ T cells share phenotypic and functional similarities with T follicular helper cells. Studies
by He et al. (2013) and Locci et al. (2013) in this issue of Immunity provide insight into their ontogeny and
functionally distinct subsets.T follicularhelper (Tfh)cellsareCD4+Tcells
specialized for providing help to B cells
(Crotty, 2011). Tfh cells are identified by a
combination ofmarkers, including the che-
mokine receptor CXCR5, costimulatory
molecules ICOS and PD-1, and the
transcription repressor BCL6. The main
effector site of Tfh cells is germinal centers
(GCs) in secondary lymphoid organs, and
GC Tfh cells selectively provide help to
high-affinity B cells and promote their sur-
vival and differentiation into memory cells
and plasma cells. Accordingly, Tfh cells
are essential for the generation of protec-
tive antibody responses, whereas exag-
gerated or dysregulated Tfh responses
cause autoimmunity. A majority of these
conclusions were obtained from mouse
studies. An important question is whether
and how these observations can be trans-
lated in human immunology and applied to
understand human disease pathogenesis.
The challenge here is an extremely limited
accessibility to secondary lymphoid
organ samples from individuals with
diseases. An alternative approach is the
analysis of blood samples. Human bloodcontains memory CXCR5+ CD4+ T cells
that share phenotypic and functional prop-
erties with Tfh cells and therefore are often
called ‘‘blood Tfh cells’’ (hereinwealso use
this term for simplicity). In this issue of Im-
munity, studies by He et al. (2013) and
Locci et al. (2013) substantially extended
the knowledge on the ontogeny and sub-
sets of blood Tfh cells.
BCL6 is not expressed by blood Tfh
cells, even by ‘‘activated’’ ICOS+ PD-1+
subsets (Bentebibel et al., 2013; Chevalier
et al., 2011; He et al., 2013; Locci et al.,
2013; Morita et al., 2011). Thus, blood
Tfh cells are different from bona fide Tfh
cells in secondary lymphoid organs, and
direct evidence demonstrating a relation-
ship between blood Tfh cells and GC
Tfh cells has been lacking. Here, He
et al. showed that similar to GC Tfh cells,
the development of blood Tfh cells was
totally dependent on ICOS and BCL6.
Furthermore, they demonstrated that
an increase of ‘‘activated’’ Tfh subset in
blood (described later) correlates with
the magnitude of newly generated Tfh
cells in secondary lymphoid organs. Ofnote, unlike GC Tfh cells, the develop-
ment of blood Tfh cells did not require
SAP or GC formation (He et al., 2013),
suggesting that the major precursors of
blood Tfh cells are developing Tfh cells
rather than GC-Tfh cells. Nonetheless,
these observations suggest that ana-
lysis of blood Tfh subsets permits the
assessment of ongoing Tfh responses.
We previously showed that blood Tfh
cells are composed of functionally dis-
tinct subsets that share properties with
Th1, Th2, and Th17 cells, defined by the
differential expression of the chemokine
receptors CXCR3 and CCR6. Importantly,
whereas CXCR3 subsets (containing
CCR6 Th2- and CCR6+ Th17-like cells)
can help naive B cells to become immu-
noglobulin-producing plasmablasts, the
CXCR3+ Th1-like subset lacks this
capacity (Bentebibel et al., 2013; Morita
et al., 2011). The two new studies show
that that PD-1 expression can define
additional aspects of human blood Tfh
subsets (He et al., 2013; Locci et al.,
2013). Accordingly, human blood Tfh
cells can be subdivided into four subsets, October 17, 2013 ª2013 Elsevier Inc. 629
